Although PKCα is infrequently mutated in CRC cells, it has been reported that PKCα expression is decreased in CRC [30], raising the question of whether PKCα overexpression and drug-induced activation are sufficient to induce its tumor suppressor function. Here, PRKCA is linked to neoplasm.